Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Protective Effect of Remote Ischemic Conditioning on Residual Renal Function in Hemodialysis Patients: A Multicenter, Randomized, Double-blind, Sham-controlled Trial.

NCT06275152 is registered in ClinicalTrials.gov with Yuanjun Yang as lead sponsor.

NCT NCT06275152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06275152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Protective Effect of Remote Ischemic Conditioning on Residual Renal Function in Hemodialysis Patients: A Multicenter, Randomized, Double-blind, Sham-controlled Trial.
Lead sponsor
Yuanjun Yang
Phase
Not applicable
Overall status
Unknown status
Start date
February 20, 2024
Completion date
January 19, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease